As of Jul 02
| -0.16 / -5.76%|
The 3 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 6.75, with a high estimate of 12.00 and a low estimate of 4.00. The median estimate represents a +157.63% increase from the last price of 2.62.
The current consensus among 3 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.